The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The ...

have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza ...

MOSCOW, September 17. /TASS/. A coronavirus vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector has proved safe during pre-clinical trials and the first ...

To probe the specific genetic variants or alleles on chromosome 3 and their potential for driving severe COVID-19, Capellini’s team used population genetics and functional genomics techniques in ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The initiative intends to track and prevent the spread of communicable, vector-borne, and water-borne diseases across the ...